{
    "clinical_study": {
        "@rank": "164704", 
        "arm_group": {
            "arm_group_label": "Women undergoing neoadjuvant therapy"
        }, 
        "brief_summary": {
            "textblock": "The hypothesis of this study is that using Koning Breast CT during the neoadjuvant treatment\n      of breast cancer will allow for accurate tumor localization and tumor volume measurement,\n      leading to improved surgical and radiation therapy outcomes."
        }, 
        "brief_title": "Koning Breast Computed Tomography Guided Neoadjuvant Treatment Monitoring", 
        "completion_date": {
            "#text": "August 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Breast Cancer", 
        "condition_browse": {
            "mesh_term": "Breast Neoplasms"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Female gender\n\n          -  Age 18 years or older\n\n          -  Any ethnicity\n\n          -  Are undergoing neoadjuvant therapy for locally advanced breast cancer with either\n             chemotherapy or hormonal therapy\n\n          -  Is able to provide informed consent.\n\n        Exclusion Criteria:\n\n          -  Pregnancy\n\n          -  Lactation\n\n          -  Women who are unable or unwilling to understand or to provide informed consent\n\n          -  Women with physical limitations that may prohibit resting prone on the exam table,\n             such as, but not limited to: frozen shoulder, recent heart surgery, pace maker.\n\n          -  Women who are unable to tolerate study constraints.\n\n          -  Women who have received radiation treatments to the thorax for malignant and\n             nonmalignant conditions, such as (but not limited to):\n\n          -  Treatment  for enlarged thymus gland as an infant\n\n          -  Irradiation for benign breast conditions, including breast inflammation after giving\n             birth\n\n          -  Treatment for Hodgkin's disease\n\n          -  Women who have participated in a prior breast clinical trial that gave additional\n             radiation dose, such as an additional mammogram.\n\n          -  Women who have received large numbers of diagnostic x-ray examinations for monitoring\n             of disease such as (but not limited to):\n\n          -  Tuberculosis\n\n          -  Severe scoliosis"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Twelve female patients at least 18 years of age undergoing neoadjuvant therapy for locally\n        advanced breast cancer with either chemotherapy or hormonal therapy will be recruited for\n        this study. Inclusion of those patients 18 years or older is important since as it is the\n        younger patients who present with breast cancer that often end up receiving neoadjuvant\n        treatment."
            }
        }, 
        "enrollment": {
            "#text": "12", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "December 13, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01771497", 
            "org_study_id": "KBCT-005"
        }, 
        "intervention": {
            "arm_group_label": "Women undergoing neoadjuvant therapy", 
            "description": "Koning Breast CT scans will be assessed at the beginning, mid-point and end of therapy.", 
            "intervention_name": "Koning Breast CT", 
            "intervention_type": "Device", 
            "other_name": "Dedicated breast CT"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": "Breast CT", 
        "lastchanged_date": "January 16, 2013", 
        "location": {
            "contact": {
                "email": "Rachel_Powell@urmc.rochester.edu", 
                "last_name": "Rachel Powell, RT", 
                "phone": "585-487-3300"
            }, 
            "facility": {
                "address": {
                    "city": "Rochester", 
                    "country": "United States", 
                    "state": "New York", 
                    "zip": "14623"
                }, 
                "name": "University of Rochester Medical Center Highland Breast Imaging Center"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_groups": "1", 
        "official_title": "Koning Breast CT (KBCT)-Guided Neoadjuvant Treatment of Breast Cancer Monitoring Phase I Trial", 
        "overall_contact": {
            "email": "avice_oconnell@urmc.rochester.edu", 
            "last_name": "Avice O'Connell, MD", 
            "phone": "(585) 487-3300"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Tumor volume will be measured with KBCT imaging at the beginning of the therapy (baseline), mid-point of the therapy (about 3 months after the treatment starts) and end of therapy (about 4-6 months after the treatment starts). The volume change from the baseline during the treatment will be recorded.\nAdverse Events will be recorded as a measure of safety.", 
            "measure": "Tumor volume change from baseline during neoadjuvant treatment", 
            "safety_issue": "Yes", 
            "time_frame": "Baseline, mid-point (~3 months), and end of therapy (4-6 months)"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01771497"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Koning Corporation", 
        "sponsors": {
            "collaborator": {
                "agency": "University of Rochester", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Koning Corporation", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "July 2010", 
        "study_design": "Observational Model: Case-Only, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "January 2013"
    }
}